INTRODUCTION {#h0}
============

*Helicobacter pylori* is a spiral, Gram-negative, microaerophilic bacterium that colonizes the gastric epithelium in about 50% of the world's population ([@B1]). *H*. *pylori* has been shown to be the etiological agent of peptic ulcer disease or chronic atrophic gastritis ([@B2]), which can subsequently develop into gastric cancers ([@B3]). Despite being a neutralophile, *H*. *pylori* successfully colonizes the extremely acidic environment of the human stomach by relying on a key enzyme, urease (UreAB). This enzyme is a nickel-containing dodecameric complex that converts urea into ammonia and carbon dioxide, thereby buffering the cytoplasm and the periplasm of the bacteria ([@B4]). It is one of the most abundant proteins synthesized by this microorganism ([@B5]), and it has been shown to be essential for colonization and persistence in different animal models ([@B6], [@B7]). Therefore, relentless efforts have focused on better understanding the transcription of the structural *ureAB* genes, as well as that of other genes involved in the Ni maturation of urease, in response to different stimuli such as pH or nickel.

The urease gene cluster in *H*. *pylori* is organized into two transcriptional units, *ureAB* and *ureIEFGH*, and produces primarily three transcripts, *ureAB*, *ureIEFGH*, and *ureABIEFGH* ([@B8]). The *ureI* gene encodes an inner membrane proton-gated channel involved in importing the urea substrate into the bacterial cell ([@B9]), and the *ureEFGH* accessory genes are required for the assembly of Ni into the urease apoenzyme (for reviews, see references 10 and 11). Based on promoter sequence comparisons, as well as transcriptional fusion studies of sequential deletions coupled with *lacZ*, it is assumed that the *ureAB* promoter belongs to the housekeeping σ^70^-dependent class of promoters ([@B8], [@B12]). Transcription of *ureAB* or *ureIFGH* has been shown to be acid induced in several independent microarrays ([@B13]--[@B15]); the acid-induced activation of both the P~ureA~ and P~ureI~ promoters is mediated directly by the phosphorylated ArsRS ([a]{.ul}cid-[r]{.ul}esponsive [s]{.ul}ignaling) two-component system ([@B16]). In addition, there is now evidence that the unphosphorylated ArsRS system represses the transcription of *ureB* through the expression of a *cis*-encoded antisense small RNA under neutral pH ([@B17]). Besides, transcription of the *ureAB* genes is also increased when Ni is added to the medium ([@B18]). This effect is mediated mostly by the Ni^2+^-responsive regulator NikR, which induces urease transcription in the presence of Ni^2+^ ([@B19], [@B20]).

In *H*. *pylori*, the hydrogenase accessory proteins HypA and HypB have also been shown to be required for maturation of urease ([@B21]). The *hypA* and *hypB* genes are located at two different loci; while *hypB* is part of a five-gene *hypBCDEF* operon, the *hypA* (*hp0869*) gene is located between the flagellar hook gene *flgE* (*hp0870*) and a gene with unknown function, the *hp0868* gene ([Fig. 1](#f1){ref-type="fig"}) ([@B22]). A few years ago, a yeast two-hybrid study aimed at discovering protein-protein interactions in *H*. *pylori* suggested that HypA and HP0868 could interact with one another (Hybrigenics PIMRider database) ([@B23]). This prompted researchers in our lab to (i) construct an *H*. *pylori hp0868* mutant to see whether urease and hydrogenase activities would be affected and (ii) express and purify HP0868 and HypA to determine if the two proteins could actually form a complex. Since an *hp0868*::*aphA3* mutant constructed in *H*. *pylori* strain 43504 had wild-type (WT) levels of urease and hydrogenase activities and since no interaction between HypA and HP0868 could be shown, we concluded that the HP0868 protein was not involved in either hydrogenase or urease maturation ([@B24]). Despite these findings, additional attempts (described herein) were made to discover a phenotype for this mutant and to characterize the role of this gene. A Δ*hp0868*::*aphA3* deletion mutant strain was generated in several *H*. *pylori* strains and grown in increasing Ni concentrations. We have found that urease activity, synthesis, and transcription were significantly higher in the Δ*hp0868* mutant background than in the WT background when cells were grown in medium supplemented with 5 or 50 µM NiCl~2~. In addition, our results indicate that the Mua protein can coordinate Ni^2+^ (2 mol per dimer). Therefore, we propose that the HP0868 (Mua) protein represses urease activity when supplies of nickel are high, thus providing a counterbalance mechanism to NikR activation.

![Physical map of the *hypA*-*mua* region in *H*. *pylori* strain 26695.](mbo0021111040001){#f1}

RESULTS AND DISCUSSION {#h1}
======================

Chromosomal location of *hp0868* and distribution among bacterial species. {#h1.1}
--------------------------------------------------------------------------

In *H*. *pylori* sequenced strain 26695 ([@B22]), the *hp0868* gene is located downstream of the *hypA* (*hp0869*) gene ([Fig. 1](#f1){ref-type="fig"}). *hypA* encodes a Ni-binding protein previously shown to be required for the maturation of both the urease and hydrogenase enzymes ([@B21]). There are homologs of HP0868 only in *Helicobacter* species, i.e., in all *H*. *pylori* strains sequenced to date (26695, J99, HPAG-1, G27, 98-10, and B128), as well as in *Helicobacter hepaticus*, *Helicobacter mustelae*, and *Helicobacter acinonychis*. In *H*. *pylori* species, the genetic organization is well conserved; *hypA* and *hp0868* homologs are located downstream of *flgE* (*hp0870* in strain 26695), a gene that encodes a protein known as the "flagellar hook" protein, and upstream of *lpxB* (*hp0867*), which encodes lipid A disaccharide synthetase ([Fig. 1](#f1){ref-type="fig"}). The organization of the locus suggests that *hypA*, *hp0868*, and *lpxB* are cotranscribed and likely constitute a 3-gene operon, as confirmed by a recent transcriptomic study ([@B25]). In addition, there is a well-conserved 59-bp-long intergenic region between *flgE* and *hypA*, suggesting that *hp0868* and *hypA* might not be cotranscribed along with *flgE*. The *hp0868* gene is annotated as hypothetical ([@B22]). However, results of a yeast two-hybrid study suggested a possible role for HP0868 in urease or/and hydrogenase maturation; indeed, a significant score was reported for a putative interaction between HP0868 and HypA ([@B23]).

Construction and genetic characterization of *Δhp0868 (Δmua)* mutant. {#h1.2}
---------------------------------------------------------------------

A *hp0868*::*aphA3* mutant constructed in *H*. *pylori* strain 43504 in our lab had WT levels of urease and hydrogenase activities, and no interaction between the purified HP0868 and HypA proteins could be detected, leading to the conclusion at the time that the *hp0868* gene was involved in neither urease nor hydrogenase activity ([@B24]). Despite these original observations, additional attempts were made to identify the role of the *hp0868* gene. To rule out the possibility of a truncated protein still being synthesized in the original strain, the *hp0868*::*aphA3* insertional mutant, a Δ*hp0868* deletion mutant, was constructed in strain 26695 (see [Table S1](#tS1){ref-type="supplementary-material"} in the supplemental material). In this mutant, 98% of the *hp0868* open reading frame (ORF) is missing. The chromosomal deletion of the *hp0868* gene following homologous recombination was confirmed by PCR (data not shown). The *aphA3* cassette used to generate the Δ*hp0868* mutant was previously described as having no polar effect on the transcription of downstream genes ([@B26]). Nevertheless, the absence of a polar effect was confirmed by reverse transcriptase PCR (RT-PCR) using primers specific for *lpxB* (see [Table S2](#tS2){ref-type="supplementary-material"} in the supplemental material). When total RNA from either the WT or the Δ*hp0868* mutant strain was used as the template, a PCR product with the expected size was obtained and there was no product in the control reaction mixture lacking RT (data not shown), confirming that *lpxB* was transcribed in the WT strain, as well as in the Δ*hp0868* mutant. Therefore, the transcription of *lpxB* is not affected by the construction of the Δ*hp0868* mutant and the phenotypes described herein are concluded to be due solely to disruption of the *hp0868* gene (herein named *mua* for [m]{.ul}odulator of [u]{.ul}rease [a]{.ul}ctivity).

The *Δmua* mutant has higher urease activity than the WT at high Ni concentrations. {#h1.3}
-----------------------------------------------------------------------------------

When WT strain 26695 and the Δ*mua* mutant were grown on non-Ni-supplemented *Brucella* agar (BA) plates, there was no significant difference in urease activity between these two strains ([Table 1](#t1){ref-type="table"}), as previously reported for the mutant 43504 *hp0868*::*aphA3* and its isogenic parental strain ([@B24]). Upon the addition of increasing NiCl~2~ concentrations to the growth medium, the urease activity concomitantly increased in the WT strain, as previously shown in several independent studies (for example, see reference 19). Interestingly, this increase was even more dramatic in the Δ*mua* mutant ([Table 1](#t1){ref-type="table"}). Indeed, when grown on plates supplemented with identical Ni concentrations, there was 25% (for 5 µM supplemental Ni) to 90% (for 50 µM supplemental Ni) higher urease activity in the Δ*mua* mutant than in the WT strain, suggesting that the *mua* gene product was acting as a repressor of urease activity, but only when ample Ni was available. The same trend was observed in other *H*. *pylori* strains into which the Δ*mua* mutation was introduced; the 43504 Δ*mua* and X47 Δ*mua* mutant strains had significantly more urease activity in the presence of high Ni concentrations (10 to 50 µM) than did the isogenic parental strains (data not shown). Likewise, the original mutant constructed in our lab (43504 *hp0868*::*aphA3*) displayed the same phenotype; the urease activity of this mutant was significantly higher than that of the WT when cells were grown in the presence of 50 µM NiCl~2~ (data not shown).

###### 

Urease activity in *H*. *pylori* parent and mutant strains as a function of nickel added to the growth medium*[^a^](#nt1.1){ref-type="fn"}*

  Strain           Urease activity at supplemental nickel concn (µM) of:                           
  ---------------- ------------------------------------------------------- -------- -------------- --------------
  WT (26695)       5 ± 1                                                   31 ± 6   158 ± 22 (a)   190 ± 15 (c)
  Δ*mua*           6 ± 2                                                   34 ± 7   195 ± 20 (a)   358 ± 54 (c)
  Δ*nikR*          6 ± 2                                                   28 ± 4   46 ± 5 (b)     46 ± 10
  Δ*mua* Δ*nikR*   5 ± 1                                                   31 ± 9   57 ± 6 (b)     46 ± 4

Urease activity is expressed as micromoles of NH~3~ produced per minute per milligram of total protein. Results shown are the mean ± standard deviation of three to seven independent experiments. Like letters after standard deviation values indicate a significant difference between the two mean values based on Student's *t* test (*P* \< 0.01).

Increased UreAB protein levels account for increased urease activity in the *Δmua* mutant. {#h1.4}
------------------------------------------------------------------------------------------

In *H*. *pylori*, it is known that the increase in urease activity under Ni-supplemented conditions is mediated mostly at the transcriptional level ([@B18]) through the action of a Ni-responsive regulator, NikR ([@B19], [@B20]). The marked increase in urease activity in the Δ*mua* mutant when supplemented with Ni (compared to that in the WT) could be due to (i) increased transcription of the structural *ureAB* genes, possibly leading to increased UreAB protein levels, or (ii) increased Ni maturation of the urease enzyme (in this case, the amount of urease would remain the same as in the WT). To test the first hypothesis, the same amount of cell-free extracts from WT strain 26695 or the Δ*mua* mutant (grown in the absence or presence of 50 µM Ni) was subjected to SDS-PAGE for direct comparison of the UreAB protein levels ([Fig. 2A](#f2){ref-type="fig"}). The amounts of UreA (26.5 kDa) and UreB (61.7 kDa) synthesized in each strain grown without supplemental Ni were similar ([Fig. 2A](#f2){ref-type="fig"}, lanes 1 and 2). The amounts of UreA and UreB increased in WT cells grown on medium with 50 µM supplemental Ni ([Fig. 2A](#f2){ref-type="fig"}, lane 3), as previously reported by van Vliet and coworkers ([@B19]); however, under these conditions (50 µM supplemental Ni), both urease subunits were unequivocally more abundant in the Δ*mua* mutant ([Fig. 2A](#f2){ref-type="fig"}, lane 4) than in the WT ([Fig. 2A](#f2){ref-type="fig"}, lane 3). The same phenotype was observed in parental strain 43504 and the isogenic Δ*mua* mutant ([Fig. 2B](#f2){ref-type="fig"}, compare lane 4 to lane 3). To confirm that the proteins whose synthesis was affected by the Δ*mua* mutation were indeed UreA and UreB, an immunoblot assay using both anti-UreA and anti-UreB antibodies was performed ([Fig. 2C](#f2){ref-type="fig"}). The immunoblot assay confirmed that the amounts of UreA and UreB were the same in the WT (strain 26695) and the Δ*mua* mutant (lanes 1 and 2); there was more urease synthesized in the Δ*mua* mutant than in the WT strain for cells grown with 50 µM supplemental Ni ([Fig. 2C](#f2){ref-type="fig"}, compare lane 4 to lane 3). Taken together, these results indicated that the marked increase in urease activity observed in Δ*mua* mutants under Ni-supplemented conditions was linked to higher urease expression, suggesting a role for Mua as a Ni-dependent transcriptional repressor of urease in *H*. *pylori*.

![Effect of Ni on urease synthesis in WT or Δ*mua* mutant bacteria. Shown is SDS-12.5% PAGE of 5 µg of cell-free extracts of WT strain 26695 or the 26695 Δ*mua* mutant (A) or WT strain 43504 and the 43504 Δ*mua* mutant (B). Cells were grown on medium without supplemental Ni (BA) or on medium with 50 µM supplemental Ni (BA 50). UreA and UreB are indicated by arrows, and the positions of molecular mass standards are indicated on the right. (C) Five micrograms of cell-free extracts of the WT strain (26695) or the 26695 Δ*mua* mutant strain grown on medium without supplemental Ni (BA) or medium with 50 µM supplemental Ni (BA 50) was subjected to SDS-PAGE, transferred to nitrocellulose, and blotted with two antisera directed to subunits UreA and UreB. (D) Cell-free extracts (1 μ each) of the Δ*nikR* or Δ*mua* Δ*nikR* mutant strain grown on medium without supplemented Ni (BA, left) or on medium with 50 µM supplemental Ni (BA 50, right) were separated on SDS-PAGE, transferred to nitrocellulose, and blotted with antiserum directed to the urease large subunit, UreB.](mbo0021111040002){#f2}

This role for Mua was further confirmed by monitoring the level of *ureA* gene expression using quantitative real-time PCR (qPCR). The WT and mutant strains were grown on medium not supplemented with NiCl~2~ or supplemented with 5 or 50 µM NiCl~2~, and total RNA was extracted and used as the template to synthesize cDNA. This cDNA was used in the qPCR to estimate the amount of *ureA* transcripts in each strain and for each Ni condition, relative to the internal control, *gyrA* ([Fig. 3](#f3){ref-type="fig"}). Compared to the non-Ni-supplemented condition, there were, on average, 3.0- and 2.8-fold more *ureA* transcripts in the WT cells grown with 5 µM and 50 µM NiCl~2~-supplemented medium, respectively ([Fig. 3](#f3){ref-type="fig"}), thus confirming the increased transcription of the *ureAB* genes in the presence of Ni in WT *H*. *pylori*. This result was in agreement with the immunoblotting results showing increased urease synthesis in the presence of Ni, as well as previously published results obtained with beta-galactosidase transcriptional fusions ([@B19]). In contrast, we found this ratio to be 5.4 with 5 µM Ni and 6.3 with 50 µM Ni for the Δ*mua* mutant ([Fig. 3](#f3){ref-type="fig"}). When the two strains were compared, this resulted in 2.1-fold (for 5 µM Ni) and 2.6-fold (for 50 µM Ni) more *ureA* transcripts synthesized in the Δ*mua* mutant than in the WT strain. There was no significant difference in urease transcription between the two strains grown on non-Ni-supplemented medium. In summary, these results indicate a role for Mua as a Ni-dependent transcriptional repressor of urease.

![Effects of nickel supplementation on the transcription of *ureA* in WT *H*. *pylori* 26695 or Δ*mua*, Δ*nikR*, or Δ*mua* Δ*nikR* mutants. The levels of *ureA* transcripts were quantified after 24 h of growth on BA medium supplemented with 0, 5, or 50 µM NiCl~2~. The relative abundance of each transcript was calculated with the 2^−Δ*CT*^ formula and using the *gyrA* gene (*hp0701*) as a housekeeping gene control. Results are the mean and standard deviation of assays performed in triplicate. The error bars shown represent 2^−Δ*CT*^ -- 2^−\[Δ*CT*\ +\ SD\]^ and 2^−\[Δ*CT*\ −\ SD\]^ -- 2^−Δ*CT*^.](mbo0021111040003){#f3}

*H. pylori* Mua represses P~ureA~-*xylE* fusions in *Escherichia coli*. {#h1.5}
-----------------------------------------------------------------------

To better understand the role of Mua, the *ureA* promoter was cloned upstream of the promotorless reporter gene *xylE*, and the resulting P~ureA~-*xylE* fusion was inserted either into the cloning vector pBS-KS or into plasmid pBS-KS into which the *mua* ORF had been cloned (in the opposite direction and under the control of P~lacZ~). Each plasmid was introduced into *E*. *coli*, and cells were grown with or without 1 mM supplemental Ni before XylE activity was measured ([Table 2](#t2){ref-type="table"}). *E*. *coli* cells provide a good background for these assays because they possess no homolog of the genes (*ureAB*, *mua*, and *xylE*) studied herein. As controls, we used the hydrogenase promoter (P~hydA~) fused to *xylE*, as well as promoterless *xylE*. The presence or absence of *mua* on plasmids harboring either *xylE* only or P~hydA~-*xylE* fusions had no effect on the respective XylE activity. In contrast, the presence of *mua* on plasmids harboring P~ureA~-*xylE* fusions led to 2.8- and 3.8-fold less XylE activity in Luria-Bertani liquid medium (LB) only and in LB with 1 mM Ni added, respectively. This suggested that *mua* was able to repress the transcription of P~ureA~-*xylE* in *E*. *coli*, thus confirming the putative role of *mua* as a transcriptional repressor of urease. Although we saw an effect of Ni on the Mua-dependent repression of P~ureA~-*xylE*, the difference does not appear to be statistically significant, suggesting that the mode of action of Mua on P~ureA~ might be different in this heterologous system.

###### 

Expression of *xylE* transcriptional fusions in *E*. *coli* as a function of Ni*[^a^](#nt2.1){ref-type="fn"}*

  Plasmid   *xylE* fusion    Presence of P~lacZ~-*mua*   XylE activity (units/10^8^ cells)   
  --------- ---------------- --------------------------- ----------------------------------- -------------
  pSB306    *xylE* only      No                          0.12 ± 0.01                         0.07 ± 0.01
  pSB328    *xylE* only      Yes                         0.22 ± 0.02                         0.17 ± 0.03
  pSB308    P~hydA~-*xylE*   No                          10.47 ± 1.10                        8.80 ± 0.29
  pSB330    P~hydA~-*xylE*   Yes                         9.50 ± 0.59                         9.08 ± 1.26
  pSB309    P~hydA~-*xylE*   No                          4.93 ± 0.31                         5.45 ± 0.25
  pSB331    P~hydA~-*xylE*   Yes                         1.78 ± 0.37                         1.43 ± 0.28

XylE activity is expressed as nanomoles of catechol oxidized per minute. Results shown are the mean ± standard deviation of two or three independent experiments.

Link between *nikR* and *mua*. {#h1.6}
------------------------------

In *H*. *pylori*, the Ni^2+^-responsive regulator NikR induces urease transcription in the presence of Ni^2+^ ([@B19], [@B20]). In order to investigate the respective roles of Mua and NikR and to determine whether Mua could still repress urease transcription in the absence of NikR under high-Ni conditions, first a single Δ*nikR*::*cat* mutant was generated in the same parental strain (26695); the Δ*nikR* mutation was also introduced into the Δ*mua*::*aphA3* mutant to generate a Δ*mua* Δ*nikR* double mutant. Both mutants were grown on non-Ni-supplemented BA or on BA supplemented with 0.5, 5, or 50 µM NiCl~2~ and subsequently characterized for urease activity ([Table 1](#t1){ref-type="table"}), urease protein synthesis ([Fig. 2D](#f2){ref-type="fig"}), and urease transcript levels ([Fig. 3](#f3){ref-type="fig"}). As previously described by several groups ([@B19], [@B20]), the deletion of the *nikR* gene in strain 26695 resulted in diminished Ni responsiveness of the urease activity ([Table 1](#t1){ref-type="table"}). In agreement with these results, immunoblotting using anti-UreB antiserum confirmed that urease synthesis was not Ni induced anymore in the Δ*nikR* mutant ([Fig. 2D](#f2){ref-type="fig"}). Besides, qPCR analysis using *ureA*-specific primers revealed a 2- to 3-fold lesser amount of *ureA* transcripts in Δ*nikR* mutant cells grown in the presence of 5 or 50 µM NiCl~2~ than under the condition with no added Ni, respectively ([Fig. 3](#f3){ref-type="fig"}). These results confirmed the central role of NikR as a primary Ni-responsive activator of urease in *H*. *pylori*.

Compared to the Δ*nikR* mutant, the Δ*mua* Δ*nikR* double mutant showed similar or slightly higher urease activity under the Ni-supplemented condition ([Table 1](#t1){ref-type="table"}); however, while there were similar amounts of UreB enzyme produced in both strains grown without added Ni ([Fig. 2D](#f2){ref-type="fig"}, left panel) or in the presence of 5 µM NiCl~2~ (data not shown), we found significantly higher UreB synthesis in the double mutant than in the Δ*nikR* mutant when cells were grown on medium supplemented with 50 µM Ni ([Fig. 2D](#f2){ref-type="fig"}, right panel). Analysis of *ureA* transcripts in the double mutant by qPCR revealed a decrease in urease transcription with Ni supplementation compared to that under the condition with no added Ni, similar to the decrease observed in the Δ*nikR* mutant ([Fig. 3](#f3){ref-type="fig"}). A comparison of the two strains (Δ*mua* Δ*nikR* and Δ*nikR* mutants) revealed similar amounts of *ureA* transcripts for cells grown with no supplemental NiCl~2~ or 5 µM supplemental Ni and about 1.5-fold more *ureA* transcripts in the double mutant when cells were grown with 50 µM supplemental NiCl~2~ ([Fig. 3](#f3){ref-type="fig"}).

Although these results suggest that Mua might repress *ureAB* in the absence of NikR at high Ni concentrations, they also clearly show that NikR remains the master regulator; indeed, all our experiments (urease assays, immunoblottings, and qPCRs) revealed that the Ni-dependent induction of urease seen in the WT strain was severely affected in the double mutant, as well as in the Δ*nikR* mutant.

Inactivation of the *mua* gene renders *H. pylori* nickel sensitive. {#h1.7}
--------------------------------------------------------------------

The effect of the *mua* deletion in the parental and Δ*nikR* mutant backgrounds was tested by comparing the growth of the WT and that of the three mutants (Δ*mua*, Δ*nikR*, and Δ*mua* Δ*nikR*) in media with increasing NiCl~2~ concentrations ([Fig. 4](#f4){ref-type="fig"}). While the growth of each of the three mutants in unsupplemented medium was not significantly different from that of the WT strain, the growth of the Δ*mua* mutant was clearly affected when concentrations equal to or higher than 0.25 mM NiCl~2~ were added to the medium ([Fig. 4](#f4){ref-type="fig"}), highlighting the importance of the *mua* gene in nickel homeostasis in *H*. *pylori*. The Δ*nikR* mutant strain was also severely affected by 0.25 mM or higher supplemental Ni concentrations, as previously reported in an independent study using similar growth conditions ([@B19]). There was no significant difference in sensitivity between the Δ*nikR* mutant and the Δ*mua* Δ*nikR* double mutant. In addition, a control experiment done with ZnCl~2~ revealed no sensitivity difference between the WT and Δ*mua* mutant strains (data not shown). The increased Ni sensitivity of the Δ*mua* mutant strain might be related to higher levels of toxic ammonia generated by urease in the presence of high Ni concentrations. Alternatively, other proteins involved in Ni efflux, Ni import, or Ni binding might be affected in the Δ*mua* mutant, although measurements of intracellular Ni pools (see below) do not support this hypothesis.

![Insertional inactivation of the *mua* and/or *nikR* gene(s) renders *H*. *pylori* Ni sensitive. WT *H*. *pylori* strain 26695 and its Δ*mua*, Δ*nikR*, and Δ*mua* Δ*nikR* isogenic mutants were grown in BHI with the indicated supplemental NiCl~2~ concentrations. Growth yield was monitored by measuring the OD~600~ 24 h after inoculation and is expressed as a percentage of the OD~600~ of the WT strain in unsupplemented medium (set at 100%; no error bar). Black bars represent WT *H*. *pylori* 26695, white bars the Δ*mua* mutant, dark grey bars the Δ*nikR* mutant, and light grey bars the Δ*mua* Δ*nikR* double mutant strain. Results shown are the averages and standard deviations of three independent growth experiments. Asterisks indicate a significant difference in growth yield between each mutant and the WT (*P* \< 0.01 for 0.25, 0.5, and 0.75 mM NiCl~2~; *P* \< 0.02 for 1 mM NiCl~2~ \[determined by Student's *t* test\]).](mbo0021111040004){#f4}

The *Δmua* mutant is more resistant to acid exposure than the WT is. {#h1.8}
--------------------------------------------------------------------

Given the higher levels of urease activity found in the Δ*mua* mutant (than in the WT) in the presence of Ni and because urease is the primary tool *H*. *pylori* cells use to combat acidity, we hypothesized that the mutant would be better than the WT at surviving acid challenges, especially if grown with supplemental Ni. Therefore, the WT and Δ*mua* mutant strains were grown on medium left unsupplemented or supplemented with 50 µM NiCl~2~ and resuspended in pH 7.4, 4.5, or 2.5 brain heart infusion broth (BHI) with 10 mM urea for 60 min. After serial dilution in BHI at pH 7.4, cells were spread on plates and colony-forming units were counted after 3 to 5 days ([Fig. 5](#f5){ref-type="fig"}). The level of survival at pH 4.5 or pH 2.5 with 10 mM urea was higher in the mutant than in the WT when cells were grown on unsupplemented BA medium. When grown on BA supplemented with 50 µM NiCl~2~, the WT cells exhibited higher resistance to acid challenge (than did WT cells grown on BA); this phenotype can probably be linked to the previously described increase in urease synthesis. Interestingly, the Δ*mua* mutant grown in the presence of Ni was more resistant to acid challenge (pH 4.5 or pH 2.5) than the WT grown under the same condition. Therefore, these results indicate that Mua, nickel, and the ability of *H*. *pylori* to survive acid challenges are linked; they also suggest that the presence of Mua is actually detrimental to *H*. *pylori* cells whenever they are confronted with high Ni concentrations coupled with acid conditions.

![The Δ*mua* mutant is more resistant to acid challenge than the WT is. WT *H*. *pylori* strain 26695 and its Δ*mua* isogenic mutant were grown on unsupplemented BA medium or BA supplemented with 50 µM NiCl~2~. Cells were harvested, resuspended in BHI at pH 7.4, pH 4.5, or pH 2.5 with 10 mM urea, and left for 60 min before being serially diluted, spread on plates, and counted a few days later. Results shown are the averages and standard deviations of three independent growth and acid challenge experiments. Asterisks indicate a significant difference between the Δ*mua* mutant and the WT strain (\*, *P* \< 0.005; \*\*, *P* \< 0.05 \[determined by Student's *t* test\]).](mbo0021111040005){#f5}

Mua dimers can bind 2 moles of nickel. {#h1.9}
--------------------------------------

*H*. *pylori* Mua was expressed in *E*. *coli* and purified to near homogeneity by using an anion-exchange step followed by size exclusion chromatography (data not shown) as previously described ([@B24]). Cross-linking and bacterial adenylate cyclase two-hybrid (BACTH) experiments indicated that Mua can form dimers in solutions (see below), and preliminary results obtained with a BIAcore Ni-nitrilotriacetic acid (NTA) chip and with Ni-NTA agarose suggested that the Mua protein can bind Ni (data not shown); however, they did not provide quantitative data. Therefore, the purified Mua protein was dialyzed against increasing concentrations of ultrapure NiCl~2~ solutions and atomic absorption spectrophotometry was used to determine the amount of Ni in the dialysis baths and within the dialysis bags. Mua was able to bind up to 2 moles of Ni^2+^ per mole of dimer ([Fig. 6](#f6){ref-type="fig"}), with half saturation at around a 20 µM Ni^2+^ ion concentration. Statistical analysis indicated positive cooperativity in nickel binding, with a Hill coefficient of approximately 3. Analysis of the amino acid sequence of Mua ([@B22]) did not reveal any significant homology with proteins of known function. The 153-amino-acid Mua protein has an unusually high content of charged amino acids, with about 22% positively (Arg or Lys) charged residues and 18% negatively (Asp or Glu) charged residues, for a total of 40% charged amino acids. Ni binding could involve two histidyl residues (His119 and His138), which are conserved among Mua homologs in all *Helicobacter* species. Site-directed mutagenesis of either residue will help determine their role in the Ni-binding ability of the purified protein and ultimately their involvement in the Ni-mediated repression of urease transcription.

![Nickel ion binding by Mua protein based on equilibrium dialysis. Purified Mua protein (3 to 4 µM dimer concentration) in 50 mM NaCl (pH 8.25) was equilibrated with the indicated concentrations of NiCl~2~, and the number of nickel ions bound per dimer was determined by graphite furnace atomic absorption spectrophotometry. Standard deviations were ≤10% for each set of measurements. SigmaPlot, version 11, was used to generate the graph, as well as to calculate the *K~D~* for Ni (50% saturation).](mbo0021111040006){#f6}

Mua does not regulate *ureAB* genes through direct binding to the P~ureA~ promoter. {#h1.10}
-----------------------------------------------------------------------------------

While it appears from the above results (higher *ureA* transcription in the *H*. *pylori* Δ*mua* mutant and lower P~ureA~-*xylE* activity in *E*. *coli* expressing Mua) that the Mua protein modulates urease activity through control of *ureA* transcription, different mechanisms could be involved. To address whether this control would be achieved by direct binding of Mua to the *ureAB* promoter (P~ureA~), electrophoretic mobility shift assays (EMSA) were carried out with ^32^P-labeled P~ureA~ and purified Mua. Since the binding of *H*. *pylori* NikR (HpNikR) to P~ureA~ has been extensively documented ([@B27]--[@B30]), T7-tagged HpNikR was expressed in *E*. *coli* and purified to homogeneity (data not shown); it was used as a positive control in our study. Various concentrations of purified Mua or purified T7-NikR (from 0 to 4 µM in 0.05-µM increments) were incubated with 100 to 200 pM of a 208-bp-long DNA sequence containing the P~ureA~ promoter. NiSO~4~ (0.8 mM) or EDTA (1 mM) was added to the mixture, the gel, and the running buffer. While the labeled P~ureA~ DNA was retarded upon incubation with T7-NikR (50 nM and higher) only in the presence of Ni^2+^, the addition of Mua did not result in retardation of labeled P~ureA~ and it did not disturb the NikR-P~ureA~ complex either (data not shown). Therefore, in contrast to the NikR regulator, Mua does not appear to regulate the *ureAB* genes by direct binding to the *ureA* promoter DNA sequence.

Alternatively, since the transcription of *ureAB* genes is under the control of NikR, as well as under the antagonistic control of ArsRS (acid induction of *ureA* by phosphorylated ArsRS, repression of *ureB* and possibly *ureA* by unphosphorylated ArsRS) ([@B16], [@B17]), we hypothesized that Mua could exert its control of *ureA* indirectly, via either NikR or ArsRS. However, EMSA carried out with Mua and the P~nikR~, the P~arsRS~ (P~hp0166~), or the antisense small RNA *ureB* promoter did not reveal any binding under the conditions tested (excess EDTA or Ni), suggesting that Mua exerts its control of urease transcription through an independent mechanism.

Interactions between Mua and other *H. pylori* proteins. {#h1.11}
--------------------------------------------------------

We investigated the possibility of Mua regulating gene transcription through binding to the housekeeping sigma factor (σ^70^ or RpoD). Indeed, yeast two-hybrid studies aimed at discovering protein-protein interactions in *H*. *pylori* suggested such an interaction; the highest possible score was reported for an interaction between HP0088 (RpoD) and HP0868 (Mua) (Hybrigenics PIMRider database) ([@B23]). Therefore, Mua and RpoD were expressed separately in *E*. *coli*, purified to near homogeneity (data not shown), and incubated alone or mixed together in the presence of the homobifunctional cross-linker dimethyl suberimidate, with or without supplemental Ni in the mixture. When Mua alone was incubated with the cross-linker for only 1 h, the protein (theoretical molecular mass of 18,411 Da) ran with an estimated mass of approximately 42 to 44 kDa, whether Ni was added to the mixture or not, indicating that Mua forms dimers in solution (data not shown). When Mua and RpoD were mixed together, a protein adduct whose apparent mass was consistent with the formation of a Mua-RpoD complex was observed in the presence of Ni, but only when proteins were incubated for an extended period (16 h) with the cross-linker (data not shown), suggesting a weak interaction, if any. When purified NikR and Mua were mixed together in the presence of the cross-linker, we did not see any protein adduct, suggesting that the two proteins do not interact *in vitro*.

To further investigate the putative RpoD-Mua interaction, as well as to test other interactions (NikR-Mua, HypA-Mua) which could have accounted for the mutants' phenotypes, we used the BACTH system based on the interaction-mediated reconstitution of the adenylate cyclase activity in *E*. *coli* ([@B31]). Cyclic AMP (cAMP) produced by the reconstituted chimeric adenylate cyclase binds to the catabolic activator protein (CAP), and the cAMP/CAP complex controls the transcription of several genes in *E*. *coli*, including *lacZ*. Each gene (*mua*, *nikR*, *hypA*, or *rpoD*) was genetically fused to the C terminus or the N terminus of the plasmid-encoded T25 fragment or the T18 fragment of the adenylate cyclase, thus generating 14 different fusions (see [Table S1](#tS1){ref-type="supplementary-material"} in the supplemental material). Next, *E*. *coli cya* mutants were cotransformed with each set of compatible plasmids and screened on solid medium (LB with isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside \[IPTG\], 5-bromo-4-chloro-3-indolyl-β-[d]{.smallcaps}-galactopyranoside \[X-Gal\], and no added Ni or 100 µM added Ni) before being assayed for beta-galactosidase activity. Among all the possible plasmid combinations, only cells harboring two plasmids with the *mua* gene (pUT18-Mua and pKT25-Mua) had significant beta-galactosidase activity, ranging from 1,925 to 2,975 Miller units per mg of bacterial dry weight (bdw), regardless of the Ni added to the medium (770 U/mg of bdw and 10,800 U/mg of bdw for the negative and positive controls provided with the kit, respectively). All other 2-plasmid combinations, involving one plasmid with *mua* and one plasmid with *rpoD*, *nikR*, or *hypA*, showed a plate phenotype and/or beta-galactosidase activity similar to those of the vector-only negative control. These results indicated that interactions between Mua and RpoD, NikR, or HypA seem unlikely or too transient to be captured under these conditions. They nevertheless confirmed that Mua can make dimers *in vivo*, in agreement with the result obtained *in vitro* with purified Mua and the cross-linker.

Finally, a comparative analysis of two-dimensional protein gels loaded with membrane-free protein extracts of WT and Δ*mua* mutant cells grown in BA with or without 50 µM supplemental Ni was carried out. Given that σ^70^ is the major sigma factor in *H*. *pylori*, one might expect a broader effect of the *mua* deletion on *H*. *pylori* proteins (besides urease). However, there was no significant difference between the WT and the mutant (data not shown). Therefore, this result suggests that RpoD is not involved in the Mua-mediated regulation of urease.

Ni levels in WT and *Δmua* mutant cells. {#h1.12}
----------------------------------------

It is possible that increased levels of intracellular Ni in Δ*mua* mutants could account for increased urease activity (and transcription). To test this hypothesis, WT strains 26695 and 43504, along with their isogenic Δ*mua* mutants, were grown in BHI (with or without 100 µM Ni added to the medium). Intracellular levels of Ni were determined by atomic absorption spectrophotometry. There was no significant difference in the amount of intracellular Ni between each WT and its isogenic mutant, at 223 ± 15 and 218 ± 28 ng Ni per mg of total protein for 26695 and 26695 Δ*mua* grown in the presence of supplemental Ni, respectively, and 361 ± 25 and 305 ± 12 ng Ni per mg of total protein for 43504 and 43054 Δ*mua* grown with supplemental Ni, respectively. Therefore, the various phenotypes observed in Δ*mua* mutants grown in the presence of Ni (urease activity and transcription, Ni toxicity) cannot be connected to larger intracellular Ni pools.

The mode of action of Mua is still not clear and requires more detailed investigation. In *H*. *pylori*, a complete set of proteins is designed to import Ni into the cell (encoded by *nixA*, *fecA3*, *frpB4*, and *exbBD*-*tonB*), to sequester it and release it when needed (Hpn, Hpn-like), and to export the metal from the cell (CznABC) to prevent the buildup of harmful Ni concentrations (for a review, see reference 11). Even with this battery of proteins, *H*. *pylori* might encounter an occasional surge in intracellular Ni. This would lead to increased apourease synthesis (mediated via NikR), a problem for *H*. *pylori* considering that it already produces huge amounts of urease ([@B5]). In addition, it is generally estimated that only a subset of the urease enzyme pool is active (i.e., Ni activated) ([@B32]); therefore, a massive and quick influx of Ni would also result in a significant portion of urease being activated at once, resulting in a massive production of ammonia that could be detrimental to the cell. This probably explains why, in the absence of Mua, increased urease activity (in the presence of a high Ni concentration) correlated with better acid resistance but also with higher Ni sensitivity. By putting a "cap" on urease activity when Ni concentrations are ample in the cell, the Mua protein would provide a safeguard mechanism. Homologs of the Mua protein can be found in all sequenced *Helicobacter* species (*H*. *pylori*, *H*. *hepaticus*, *H*. *mustelae*, and *H*. *acinonychis*). Therefore, this dual Ni-dependent fine-tuning (by NikR and Mua) of urease seems to constitute yet another hallmark of the *Helicobacter* genus.

MATERIALS AND METHODS {#h2}
=====================

Bacterial strains, plasmids, and primers. {#h2.1}
-----------------------------------------

The *E*. *coli* and *H*. *pylori* strains and the plasmids used in this study are listed in [Table S1](#tS1){ref-type="supplementary-material"} in the supplemental material. The primers used in this study are listed in [Table S2](#tS2){ref-type="supplementary-material"}. All plasmids and PCR products used to generate *H*. *pylori* mutants, to overexpress the Mua, NikR, or RpoD protein in *E*. *coli*, or to express *xylE* transcriptional fusions in *E*. *coli* were sequenced at the Sequencing and Synthesis Facility of the University of Georgia, Athens, GA, and compared to DNA sequences from strain 26695 ([@B22]) to ensure that no error had been introduced following PCR amplification.

Growth conditions. {#h2.2}
------------------

*E*. *coli* cells were grown aerobically in LB (liquid or) plates at 37°C. *H*. *pylori* was routinely grown on brucella agar plates supplemented with 10% defibrinated sheep blood (BA plates) at 37°C under microaerophilic conditions with 5% O~2~, 5% CO~2~, and 90% N~2~. For liquid growth, BHI with 0.4% β-cyclodextrin was used and cultures were grown in 10 ml of medium in 165-ml sealed glass bottles containing 5% CO~2~, 10% H~2~, 75% N~2~, and 10% O~2~. When needed, media were supplemented with ampicillin, kanamycin, or chloramphenicol to a final concentration of 100 µg/ml, 30 µg/ml, or 25 µg/ml, respectively. For nickel toxicity assays, *H*. *pylori* grown in BA was resuspended in BHI and inoculated to a final optical density at 600 nm (OD~600~) of 0.05 in 10 ml of BHI supplemented with 0.4% β-cyclodextrin and either no NiCl~2~ or 250, 500, 750, 1,000, 1,500, or 2,000 µM NiCl~2~. Cultures were shaken at 200 rpm for 24 h at 37°C, and growth (resistance to Ni toxicity) was determined by measuring the OD~600~. Results are the average of three to five independent experiments and are given as percentages of the average OD~600~ of the WT cells grown for 24 h without Ni. For acid challenge experiments, the protocol described by Wen et al. ([@B33]) was followed, with slight modification. Briefly, *H*. *pylori* cells grown in BA plates not supplemented with NiCl~2~ or supplemented with 50 µM NiCl~2~ were resuspended to a final OD~600~ of 0.1 in BHI at pH 7.4, 4.5, or 2.5, the latter supplemented with 10 mM urea. After 60 min, cells were serially diluted for CFU counting in BHI at pH 7.4, spread onto BA plates, and incubated for 3 to 5 days in a microaerobic atmosphere at 37°C. The average number of colony-forming units per milliliter in the original suspension was calculated. Results are the average of three independent growth (followed by acid challenge) experiments.

Construction of mutants. (i) Construction of *Δmua* mutant. {#h2.3}
-----------------------------------------------------------

An overlapping PCR method was used to construct the Δ*mua* mutant. Genomic DNA from strain 26695 and primers Δmua1 and Δmua2-kan (see [Table S2](#tS2){ref-type="supplementary-material"} in the supplemental material) were used to amplify a 406-bp-long DNA sequence that contained part of the *hp0867* gene, the last three codons of *hp0868*, and part of the *aphA3* (Kan^r^) gene; primers Δmua3-kan and Δmua4 (see [Table S2](#tS2){ref-type="supplementary-material"}) were used to amplify a 379-bp-long DNA sequence that contained the *hp0869* gene and part of the *aphA3* gene. Each PCR product was gel purified and mixed together along with a purified 1.3-kbp-long *aphA3* cassette. The final elongation step with primers Δmua1 and Δmua4 yielded a 2.1-kbp PCR product that was cloned into the pGEM-T vector to generate plasmid pGEM-Δ*mua*::*aphA3*. This plasmid was introduced into various *H*. *pylori* strains by natural transformation to generate Δ*mua* mutants. *H*. *pylori* cells were transferred after 16 h onto BA plates supplemented with 30 µg/ml kanamycin; clones appeared after 3 to 5 days of incubation. The disruption of the *mua* gene by homologous recombination was confirmed by PCR using genomic DNA from each mutant as the template and primers Δmua1 and Δmua4; a 2.1-kbp PCR product was visualized on a 0.7% Tris-acetate-EDTA (TAE) agarose gel.

(ii) Construction of *ΔnikR* single mutant and *Δmua ΔnikR* double mutant. {#h2.4}
--------------------------------------------------------------------------

The Δ*nikR* mutant was generated using an overlapping PCR method. Genomic DNA from strain 26695 and primers ΔnikR1 and ΔnikR2-cat (see [Table S2](#tS2){ref-type="supplementary-material"}) were used to amplify a 373-bp-long DNA sequence containing the intergenic region between *hp1338* (*nikR*) and *hp1339*, part of *nikR*, and the beginning of a *cat* cassette; in a separate PCR, primers ΔnikR3-cat and ΔnikR4 were used to amplify a 300-bp-long sequence complementary to the end of *nikR*, part of *hp1337*, and the end of the *cat* cassette. The final amplification step included each PCR product and an 800-bp-long *cat* cassette (with its own promoter and no transcription termination sequence), as well as primers ΔnikR1 and ΔnikR4. The resulting 1,470-bp-long PCR product was introduced into *H*. *pylori* 26695 to generate a Δ*nikR*::*cat* mutant. This PCR product was also introduced into the Δ*mua* mutant to create a Δ*mua* Δ*nikR* double mutant. Mutants were isolated on BA supplemented with chloramphenicol. Following homologous recombination, the disruption of the *nikR* gene was confirmed by PCR using genomic DNA from each mutant as the template and primers ΔnikR1 and ΔnikR4; a 1.47-kbp PCR product was visualized on a 0.7% TAE agarose gel.

Construction of transcriptional *xylE* fusions and XylE assays. {#h2.5}
---------------------------------------------------------------

The promoterless *Pseudomonas putida xylE* reporter gene ([@B34]) was digested with PstI and XhoI and cloned into pBluescript-KS to generate plasmid pSB306. Primers ureAPstI and ureABamHI (see [Table S2](#tS2){ref-type="supplementary-material"}) were designed to amplify a DNA sequence that corresponded to positions −140 to +49 relative to the transcription start site of *H*. *pylori ureAE*, which was determined previously ([@B8]). Similarly, a region of DNA corresponding to positions −152 to −6 relative to the translation start site of *H*. *pylori hydA* was amplified using primers hydAPstI and hydABamHI (see [Table S2](#tS2){ref-type="supplementary-material"}). Each PCR product was digested with PstI and BamHI and cloned into plasmid pSB306 to generate a P~ureA~-*xylE* or P~hydA~-*xylE* transcriptional fusion, respectively (plasmid pSB308 or pSB309). Finally, the *hp0868* ORF was amplified using primers Mua-Kpn2 and Mua-SacI, digested with KpnI and SacI, and cloned into pSB306, pSB308, or pSB309 to generate plasmid pSB328, pSB330, or pSB331, respectively. In each plasmid, the *hp0868* gene is placed under the control of the *lacZ* promoter (opposite direction from *xylE* fusions). XylE activity was measured as described previously ([@B35]). *E*. *coli* strains containing the *xylE* reporter plasmids were grown in LB with or without 1 mM supplemental NiCl~2~ for 24 h, harvested, and then resuspended in 50 mM phosphate buffer, pH 7.4, to a cell density (OD~600~) of 1 (7 × 10^8^ CFU/ml). Whole cells (50 to 100 µl) were added to a mixture containing 10 mM catechol in 50 mM potassium phosphate, pH 7.4. Catechol oxidation to 2-hydroxymuconic semialdehyde was monitored continuously at 375 nm. A unit of XylE activity corresponds to 1 nmol of catechol oxidized per min, and values were expressed as units per 10^8^ cells. The results are the mean ± standard deviation for two or three independent assays (three to five replicates per assay).

BACTH system. {#h2.6}
-------------

The BACTH system was purchased from Euromedex. Primers were designed to introduce XbaI and KpnI restriction sites and to PCR amplify *mua*, *rpoD*, *hypA*, or *nikR* (see [Table S2](#tS2){ref-type="supplementary-material"}). Each PCR product was gel purified and digested with XbaI and KpnI before being ligated into plasmid pUT18, pUT18C, pKT25, or pKNT25, thus generating 12 different plasmids with *mua*, *rpoD*, *hypA*, or *nikR* fused in frame with either the T18 or the T25 peptide (N- or C-terminal fusion) of *Bordetella pertussis* adenylate cyclase. *E*. *coli* BTH101 *cya* mutant cells were cotransformed with each set of compatible plasmids and screened on LB plates supplemented with antibiotics, 0.1 mM IPTG, and 40 µg/ml of X-Gal, with or without 100 µM NiCl~2~. Beta-galactosidase assays were performed as described by Miller ([@B36]). One Miller unit equals 1 nmol of *ortho*-nitrophenol released per min.

RNA isolation. {#h2.7}
--------------

Total RNA was isolated from *H*. *pylori* WT or mutant cells grown for 24 h on BA plates not supplemented with NiCl~2~ or supplemented with 5 or 50 µM NiCl~2~ by using the Aurum total isolation kit (Bio-Rad, Hercules, CA) and the Turbo DNA-free kit (Ambion, Austin, TX). Total RNA from each sample was analyzed on nondenaturing 1.2% agarose gel and quantified by spectrophotometry after dilution in diethyl pyrocarbonate-treated water.

cDNA synthesis. {#h2.8}
---------------

cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad) and 200 ng of DNA-free total RNA as the template. The protocol included a brief denaturation step at 95°C, followed by 5 min at 25°C (annealing with random primers), 30 min at 42°C (reverse transcription), and 5 min at 85°C (inactivation of RT). The cDNA generated was used as the template for the qPCR experiments.

qPCR. {#h2.9}
-----

Primers were designed to amplify 100- to 300-bp regions of the *ureA* or *gyrA* (internal control) gene (see [Table S2](#tS2){ref-type="supplementary-material"}). A reaction mixture containing the master mix with SYBR green (Bio-Rad) and each set of primers was added to a 96-well plate along with diluted cDNA samples for a final reaction volume of 20 µl per well. Negative controls contained the reaction mixture but no DNA. Samples were incubated in an iCycler (Bio-Rad) for 45 cycles (15 s at 95°C, 30 s at 58°C, and 30 s at 72°C). Gene expression was quantified by the comparative *C~T~* (cycle threshold) method and normalized to the *gyrA* housekeeping gene's *C~T~* in each sample. The relative abundance of each transcript was calculated by using the 2^−Δ*CT*^ formula. Error bars correspond to 2^−Δ*CT*^ − 2^−\[Δ*CT*\ +\ SD\]^ and 2^−\[Δ*CT*\ −\ SD\]^ − 2^−Δ*CT*^, where SD = √\[(SD1 *C~T~ ureA*)^2^ + (SD2 *C~T~ gyrA*)^2^\]. Results shown are from assays done in triplicate for one growth experiment. The same patterns were seen for two additional (independent) growth experiments.

RT-PCR. {#h2.10}
-------

The expression of the *hp0867* gene in the WT and the Δ*mua* mutant was analyzed by RT-PCR using the one-step RT-PCR kit from Qiagen (Valencia, CA). Total RNA isolated from the WT strain (26695) or the Δ*mua* mutant grown in BA was used as the template. Positive controls were performed with genomic DNA from either strain as the template, and negative controls were performed with RNA that had not been subjected to retrotranscription. Primers Hp0867F and Hp0867R were used to amplify an *hp0867*-specific 741-bp-long PCR product (see [Table S2](#tS2){ref-type="supplementary-material"}). After the final PCR amplification step, 10 µl of the reaction mixture was loaded onto an agarose gel.

Urease assays. {#h2.11}
--------------

Urease activities were determined as previously described ([@B24]), by following the method of Weatherburn ([@B37]). The results are the mean ± standard deviation for three to seven independent assays (performed in duplicate).

Immunoblottings. {#h2.12}
----------------

Immunoblottings were done as previously described ([@B24]), with either anti-UreA or anti-UreB antibody (1:5,000 dilution).

Equilibrium dialysis and nickel determination. {#h2.13}
----------------------------------------------

The Ni-binding ability of the purified Mua protein was determined by equilibrium dialysis, followed by graphite furnace atomic absorption spectrophotometry (Shimadzu AA-6701F). Briefly, the purified Mua protein (3 to 4 µM dimer) was left for 48 h at 4°C in 6 independent dialysis baths of 1 liter each composed of 50 mM ultra pure NaCl (pH 8.25) and increasing concentrations of NiCl~2~ (0, 10, 20, 30, 40, and 50 µM). After dialysis, the protein concentration in each dialysis bag was determined again and the nickel concentrations of the protein solution (bound plus free Ni^2+^) and the dialysis buffer (free Ni^2+^) were measured. The concentration of protein-bound nickel was estimated by subtracting the two values. Results are the average of three to five sets of measurements, with each measurement set representing three to seven injections; standard deviations were ≤10% for each set of measurements. A SigmaPlot, version 11, graphical program was used to generate the graph shown ([Fig. 6](#f6){ref-type="fig"}). The program was also used to fit a curve, %S = f(log\[Ni^2+^\]), with the equation %S = \[Ni^2+^\]*^n^*/(\[EC~50~\]*^n^* + \[Ni^2+^\]*^n^*), where %S is percent saturation, EC~50~ is the effective concentration of Ni^2+^ at 50% saturation, and *n* is the estimated Hill coefficient.

Measurements of Ni levels in cells. {#h2.14}
-----------------------------------

*H*. *pylori* WT and Δ*mua* mutant cells were grown for 18 h in Ni-unsupplemented BHI or BHI supplemented with 100 µM NiCl~2~, pH 6.5, in sealed bottles before being harvested, washed once, and resuspended in ice-cold deionized water and broken by sonication. The amount of Ni in the cell extracts was determined using graphite furnace atomic absorption spectrophotometry (Shimadzu AA-6701F), and the amount of total protein was determined using the bicinchoninic acid assay kit.

Two-dimensional electrophoresis. {#h2.15}
--------------------------------

Cell-free, membrane-free protein extracts from *H*. *pylori* (26695 and 26695 Δ*mua*) cells grown in BA or in BA supplemented with 50 µM NiCl~2~ were sent to Kendrick Laboratories (Madison, WI) for processing and data analysis.

SUPPLEMENTAL MATERIAL {#h3}
=====================

###### TEXT S1
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###### TABLE S2 Primers used in this study.
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